Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Ford

Showing results (41-50 of 458) with videos related to

Pageof 46
Sort By:
BMJ (Clinical Research Ed.)|January 7, 2011
Research into scorpion stingsEdward J Mills, Nathan Ford
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Home-based HIV counseling and testing as a gateway to earlier initiation of antiretroviral therapyEdward J Mills, Nathan Ford
Lancet (London, England)|April 20, 2002
Generic medicines are not substandard medicinesNathan Ford, Ellen 't Hoen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
World Health Organization Guidelines on Postexposure Prophylaxis for HIV: Recommendations for a Public Health ApproachNathan Ford, Kenneth H Mayer,
Plos Medicine|August 4, 2011
Simplified ART delivery models are needed for the next phase of scale upNathan Ford, Edward J Mills
The Lancet. Global Health|August 16, 2017
Improving the quality of WHO guidelines over the last decade: progress and challengesSusan L Norris, Nathan Ford
Tropical Medicine & International Health : TM & IH|December 15, 2010
Defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definitionAnna Grimsrud, Nathan Ford, Landon Myer
The New England Journal of Medicine|June 25, 2004
HIV drug resistanceAlexandra Calmy, Fernando Pascual, Nathan Ford
Lancet (London, England)|July 28, 2004
First-line and second-line antiretroviral therapyAlexandra Calmy, Fernando Pascual, Nathan Ford
BMC International Health and Human Rights|April 2, 2010
When to start antiretroviral therapy in resource-limited settings: a human rights analysisNathan Ford, Alexandra Calmy, Samia Hurst
Pageof 46

Showing results (41-50 of 458) with videos related to

Sort By:
Pageof 46
BMJ (Clinical Research Ed.)|January 7, 2011
Research into scorpion stingsEdward J Mills, Nathan Ford
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Home-based HIV counseling and testing as a gateway to earlier initiation of antiretroviral therapyEdward J Mills, Nathan Ford
Lancet (London, England)|April 20, 2002
Generic medicines are not substandard medicinesNathan Ford, Ellen 't Hoen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2015
World Health Organization Guidelines on Postexposure Prophylaxis for HIV: Recommendations for a Public Health ApproachNathan Ford, Kenneth H Mayer,
Plos Medicine|August 4, 2011
Simplified ART delivery models are needed for the next phase of scale upNathan Ford, Edward J Mills
The Lancet. Global Health|August 16, 2017
Improving the quality of WHO guidelines over the last decade: progress and challengesSusan L Norris, Nathan Ford
Tropical Medicine & International Health : TM & IH|December 15, 2010
Defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definitionAnna Grimsrud, Nathan Ford, Landon Myer
The New England Journal of Medicine|June 25, 2004
HIV drug resistanceAlexandra Calmy, Fernando Pascual, Nathan Ford
Lancet (London, England)|July 28, 2004
First-line and second-line antiretroviral therapyAlexandra Calmy, Fernando Pascual, Nathan Ford
BMC International Health and Human Rights|April 2, 2010
When to start antiretroviral therapy in resource-limited settings: a human rights analysisNathan Ford, Alexandra Calmy, Samia Hurst
Pageof 46